Presentation of Alzheimer’s Disease in Clinical Practice

Now Viewing

EP: 1.Presentation of Alzheimer’s Disease in Clinical Practice

EP: 2.Diagnosis and Treatment of Alzheimer’s Disease

Summary for Physicians

Symptoms Leading to a Diagnosis of Mild Cognitive Impairment (MCI)

Patients are typically diagnosed with MCI when they present with the following clinical features:

• Noticeable cognitive decline: This is most often reported by the patient, family members, or caregivers. Memory issues (e.g., forgetting recent events or conversations) are the most common complaints.

• Objective cognitive impairment: Documented through standardized cognitive testing, with performance below age- and education-adjusted norms.

• Preserved functional abilities: Despite cognitive challenges, individuals maintain independence in daily activities, though they may be less efficient or need more time.

• Absence of dementia: The cognitive decline is not severe enough to significantly impair social or occupational functioning.

MCI may be amnestic (primarily affecting memory) or non-amnestic (impacting other cognitive domains such as language, attention, or visuospatial skills). It often represents an early stage of Alzheimer’s disease, but not all cases progress to dementia.

Operational Workflow and Access to Alzheimer’s Disease Care

Effective Alzheimer’s care requires coordinated workflows and multidisciplinary access points:

• Early Identification & Referral: Primary care providers (PCPs) are often the first to identify cognitive concerns. Standardized screening tools (e.g., MoCA, MMSE) aid in determining need for specialist referral.

• Specialty Care Access: Access to neurologists, geriatric psychiatrists, and memory clinics is critical but often limited. Telehealth is helping bridge access gaps, especially in rural or underserved areas.

• Diagnostic Workflow:

• Comprehensive clinical assessment

• Neuropsychological testing

• Neuroimaging (MRI, PET scans)

• Laboratory tests to rule out reversible causes

• Emerging tools include blood-based biomarkers and amyloid/tau PET imaging

• Care Coordination: Multidisciplinary teams (including social workers, pharmacists, and care navigators) are essential for managing comorbidities, planning care, and supporting patients and caregivers.

• Barriers to Access: Include long wait times, limited specialist availability, underdiagnosis in minority populations, and challenges navigating insurance coverage.

• Emerging Innovations: Value-based care models, cognitive care pathways, and digital platforms for early screening and care navigation are improving operational efficiency and patient outcomes.